Purchases and Sales Made in Q4 2022 in Immix Biopharma, Inc. (IMMX)
This table provides information about the institutional ownership of Immix Biopharma, Inc. (IMMX) during Q4 2022. The information is specifically focused on institutions that hold shares of Immix Biopharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 10, 2023
Q4 2022
|
Murchinson Ltd.
Toronto, A6 |
BUY
|
- |
67.2KNew |
$50.4K - $163K
|
67.2K
$148K
|
|
|
Feb 14, 2023
Q4 2022
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
- |
33.6KNew |
$25.2K - $81.6K
|
33.6K
$73.9K
|
|
|
Feb 07, 2023
Q4 2022
|
Lynwood Capital Management Inc.
|
BUY
|
- |
25KNew |
$18.8K - $60.8K
|
25K
$55K
|
|
|
Dec 20, 2023
Q4 2022
|
Moss Adams Wealth Advisors LLC
Seattle, WA |
BUY
|
- |
20KNew |
$15K - $48.6K
|
20K
$44K
|
|
|
Feb 01, 2023
Q4 2022
|
Bank Of Montreal
Toronto, A6 |
BUY
|
- |
15KNew |
$11.3K - $36.5K
|
15K
$33K
|
|
|
Feb 14, 2023
Q4 2022
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
12.6KNew |
$9.45K - $30.6K
|
12.6K
$27.7K
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
2.11K+ 842.4% |
$1.58K - $5.12K
|
2.36K
$5.18K
|
|
|
Feb 10, 2023
Q4 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
232+ 0.22% |
$174 - $564
|
105K
$232K
|
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
10New |
$7.5 - $24.3
|
10
$22
|
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1+ 2.78% |
$0.75 - $2.43
|
37
$81.4
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-2- 66.67% |
$1.5 - $4.86
|
1
$2.2
|
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-232- 0.3% |
$174 - $564
|
76.5K
$168K
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
SELL
|
- |
-7.32K- 60.95% |
$5.49K - $17.8K
|
4.69K
$10.3K
|